Maryland 2024 Regular Session

Maryland House Bill HB86

Introduced
1/10/24  
Refer
1/10/24  
Report Pass
3/11/24  
Engrossed
3/13/24  
Refer
3/14/24  
Report Pass
4/3/24  
Enrolled
4/5/24  
Chaptered
4/25/24  

Caption

Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies

Impact

The bill is expected to have a significant impact on state laws regarding emergency medical responses in schools. It introduces standardized training across public and nonpublic schools to improve the readiness of staff to respond to life-threatening conditions such as anaphylaxis and severe asthma attacks. The legislation also emphasizes the importance of having these life-saving medications readily available in schools, potentially enhancing student safety and health outcomes. By allowing school personnel to administer these medications without requiring prior prescriptions, the bill aims to streamline emergency interventions and remove barriers that might delay treatment.

Summary

House Bill 86, titled 'Public and Nonpublic Schools - Auto-Injectable Epinephrine and Bronchodilators - Use, Availability, Training, and Policies,' mandates that each county board of education in Maryland establishes policies to ensure that school personnel can administer auto-injectable epinephrine and bronchodilators in emergency situations. The bill highlights the need for effective training for school nurses and other staff to recognize the symptoms of anaphylaxis, asthma, and other respiratory issues in students. This legislation reflects a growing awareness of the need for timely medical responses in school environments, especially as food allergies and asthma become increasingly common among children.

Sentiment

General sentiment surrounding HB 86 seems to be positive, reflecting a proactive approach to health and safety in schools. Supporters argue that the measure is vital for protecting students who may experience severe allergic reactions or asthma-related crises. They emphasize that timely administration of epinephrine or bronchodilators can be lifesaving. However, concerns were raised by some who worry about the adequacy of training and the potential burden of implementing these policies on schools, particularly nonpublic institutions that may have fewer resources for compliance.

Contention

Notable points of contention include potential concerns over the adequacy of training provided to school personnel and the logistics of maintaining adequate supplies of auto-injectable epinephrine and bronchodilators. Critics may also raise questions regarding the liability implications for school staff administering medications, despite provisions in the bill aimed at protecting them from legal repercussions for good faith actions. This discussion reflects broader debates on how best to balance safety, responsibility, and accessibility of medical care within school systems.

Companion Bills

MD SB180

Crossfiled Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies

MD HB266

Carry Over Public and Nonpublic Schools - Bronchodilator Availability and Use - Policies

Similar Bills

MD SB180

Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies

MD HB384

Public and Nonpublic Schools - Bronchodilator and Epinephrine Availability and Use - Policies

MD HB266

Public and Nonpublic Schools - Bronchodilator Availability and Use - Policies

KY HB384

AN ACT relating to intranasal epinephrine.

HI HB903

Relating To Student Health.

MT HB600

Authorize emergency use of albuterol in a school setting

HI HB1448

Relating To Asthma.

HI SB1443

Relating To Asthma.